JP2004511492A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004511492A5 JP2004511492A5 JP2002534368A JP2002534368A JP2004511492A5 JP 2004511492 A5 JP2004511492 A5 JP 2004511492A5 JP 2002534368 A JP2002534368 A JP 2002534368A JP 2002534368 A JP2002534368 A JP 2002534368A JP 2004511492 A5 JP2004511492 A5 JP 2004511492A5
- Authority
- JP
- Japan
- Prior art keywords
- bikunin
- plasma fraction
- protein
- plasma
- chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101800001691 Inter-alpha-trypsin inhibitor light chain Proteins 0.000 claims 18
- 102100032859 Protein AMBP Human genes 0.000 claims 18
- 101710081722 Antitrypsin Proteins 0.000 claims 5
- 230000001475 anti-trypsic effect Effects 0.000 claims 5
- 230000000694 effects Effects 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 239000002753 trypsin inhibitor Substances 0.000 claims 5
- 108010093564 inter-alpha-inhibitor Proteins 0.000 claims 3
- 238000004587 chromatography analysis Methods 0.000 claims 2
- 238000001542 size-exclusion chromatography Methods 0.000 claims 2
- 102000003966 Alpha-1-microglobulin Human genes 0.000 claims 1
- 101500025163 Homo sapiens Inter-alpha-trypsin inhibitor light chain Proteins 0.000 claims 1
- 206010040047 Sepsis Diseases 0.000 claims 1
- 238000001042 affinity chromatography Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 238000004255 ion exchange chromatography Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10050665 | 2000-10-13 | ||
| PCT/EP2001/011994 WO2002030983A2 (de) | 2000-10-13 | 2001-10-11 | Bikunin enthaltende plasmafraktion, verfahren zu ihrer herstellung und ihrer verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004511492A JP2004511492A (ja) | 2004-04-15 |
| JP2004511492A5 true JP2004511492A5 (https=) | 2005-03-17 |
Family
ID=7659599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002534368A Pending JP2004511492A (ja) | 2000-10-13 | 2001-10-11 | ビクニンを含む血漿画分、その調製方法、およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20030190732A1 (https=) |
| EP (1) | EP1326893A2 (https=) |
| JP (1) | JP2004511492A (https=) |
| AU (1) | AU2002216968A1 (https=) |
| WO (1) | WO2002030983A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007536206A (ja) * | 2003-10-16 | 2007-12-13 | バイエル・ヘルスケア・エルエルシー | 尿中トリプシンインヒビターを検出するためのモノクローナル抗体 |
| EP3087991A1 (en) * | 2003-11-08 | 2016-11-02 | Prothera Biologics | Composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| CN103142650B (zh) * | 2004-11-05 | 2016-05-11 | 普罗瑟拉生物公司 | 治疗用途的来自人血浆的内-α抑制剂蛋白质的制备和组合物 |
| CN101160133B (zh) * | 2004-11-05 | 2013-01-09 | 普罗瑟拉生物公司 | 治疗用途的来自人血浆的内-α抑制剂蛋白质的制备和组合物 |
| FR2894145B1 (fr) * | 2005-12-07 | 2008-10-17 | Lab Francais Du Fractionnement | Utilisation de facteur h du complement a titre de medicament |
| CN106928346B (zh) * | 2008-05-28 | 2021-09-07 | 普罗瑟拉生物公司 | 来自血液的间-α抑制物蛋白的制备和组合物 |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| WO2011150284A2 (en) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| SG187599A1 (en) | 2010-07-23 | 2013-03-28 | Baxter Int | Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma |
| WO2014039987A2 (en) | 2012-09-09 | 2014-03-13 | Prothera Biologics, Inc. | Treatment of disease using inter-alpha inhibitor proteins |
| US20140206844A1 (en) | 2013-01-18 | 2014-07-24 | Prothera Biologics | Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material |
| WO2018053029A1 (en) | 2016-09-13 | 2018-03-22 | Prothera Biologics, Inc. | Methods for treating pulmonary disease using inter-alpha inhibitor proteins |
| BR112019022358A2 (pt) | 2017-04-25 | 2020-05-19 | Prothera Biologics, Inc. | métodos para quantificar proteínas inibidoras inter-alfa |
| US20230416342A1 (en) | 2020-11-16 | 2023-12-28 | Prothera Biologics, Inc. | Methods for purifying inter-alpha inhibitor proteins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5846763A (en) * | 1991-01-14 | 1998-12-08 | New York University | DNA encoding tumor necrosis factor stimulated gene 6 (TSG-6) |
| FR2711371B1 (fr) * | 1993-10-18 | 1995-12-29 | Aetsrn | Procédé de préparation d'un concentré d'inter-alpha-trypsine inhibiteur à usage thérapeutique et concentré obtenu. |
-
2001
- 2001-10-11 EP EP01986698A patent/EP1326893A2/de not_active Withdrawn
- 2001-10-11 AU AU2002216968A patent/AU2002216968A1/en not_active Abandoned
- 2001-10-11 WO PCT/EP2001/011994 patent/WO2002030983A2/de not_active Ceased
- 2001-10-11 JP JP2002534368A patent/JP2004511492A/ja active Pending
- 2001-10-11 US US10/381,440 patent/US20030190732A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004511492A5 (https=) | ||
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| WO2003092624A3 (en) | Use of heat shock proteins to enhance efficacy of antibody therapeutics | |
| EP1539234A4 (en) | METHOD FOR PREVENTING OR TREATING CELL MALIGNITY BY ADMINISTERING CD2 ANTAGONISTS | |
| BRPI0407662A (pt) | derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas | |
| WO2004064717A3 (en) | Cop 1 for treatment of inflammatory bowel diseases | |
| BR0114390A (pt) | éteres de 7-desmetilrapamicina | |
| DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
| WO2002058638A3 (en) | Serpin drugs for treatment of hiv infection and method of use thereof | |
| DE60144514D1 (de) | Verwendung von il-18 inhibitoren | |
| ATE245977T1 (de) | Therapeutische substituierte guanidine | |
| ATE234111T1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
| ATE427116T1 (de) | Behandlung von bakteriellen infektionen | |
| ATE407947T1 (de) | Proteine mit il-6 inhibitorischer wirkung | |
| WO2005046587A3 (en) | Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use | |
| WO2003087138A3 (en) | Methods for identifying polypeptide factors interacting with rna | |
| HRP20140888T1 (hr) | Humana monoklonalna protutijela za humani il-4 | |
| WO2004065406A3 (en) | Rantes-derived peptides with anti-hiv activity | |
| WO2005009366A3 (en) | Restoring vascular function | |
| BR0206819A (pt) | Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca | |
| EP1075840A3 (de) | Verwendung von Antithrombin III zur Prophylaxe und Therapie von Erkrankungen | |
| DE60113664D1 (de) | Zusammensetzung zur behandlung von herzinsuffizienz | |
| WO2002094881A3 (en) | Monoclonal antibody neutralising cathepsin b activity and uses thereof | |
| WO2001007479A3 (en) | Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases | |
| AU4568400A (en) | Sphingomyelinase inhibitor |